Keyphrases
Population-based
100%
Cancer Surveillance
100%
Prostate Cancer
100%
Active Surveillance
100%
Watchful Waiting
71%
Prostate-specific Antigen Testing
28%
Office Visits
28%
Active Treatment
28%
Surveillance Strategy
28%
Medicare Data
14%
Year of Diagnosis
14%
Surveillance Epidemiology
14%
Regression Analysis
14%
Confidence Interval
14%
Hazard Ratio
14%
Prostate Biopsy
14%
Overtreatment
14%
Localized Prostate Cancer
14%
Expectant Management
14%
Surveillance Quality
14%
Patients with Prostate Cancer
14%
Bivariate Regression
14%
Indolent Prostate Cancer
14%
Data-limited
14%
Medicine and Dentistry
Cancer Epidemiology
100%
Prostate Cancer
100%
Watchful Waiting
83%
Decision Making
16%
Medicare
16%
Surveillance, Epidemiology, and End Results
16%
Hazard Ratio
16%
Prostate Biopsy
16%
Prostate Specific Antigen Test
16%
Prostate Specific Antigen
16%
Overdiagnosis
16%
Nursing and Health Professions
Prostate Cancer
100%
Cancer Epidemiology
100%
Watchful Waiting
83%
Prostate Specific Antigen
33%
Ambulatory Care
33%
Medicare
16%
Confidence Interval
16%
Hazard Ratio
16%
Prostate Biopsy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Epidemiology
100%
Prostate Cancer
100%
Prostate Specific Antigen
33%